Latest News
All Times Eastern
- My wife wants us to spend $5,000 to attend her cousin’s destination wedding. I don’t want to go. Am I being selfish?
- ‘I feel used’: My partner stays with me 5 nights a week, even though he owns his own home. Should he pay for utilities and food?
- DeSantis promises to make America Florida. But Florida isn’t Florida anymore, critics say.
- Special counsel Durham to testify before House committee on June 20 about his investigate-the-investigators report
- From solemn reflection to ‘three-day hootenanny’: the evolution, and degradation, of the Memorial Day holiday
- How much does a mammogram cost? That depends on whether it’s ‘diagnostic’ or ‘screening.’
- How Joe Biden and Kevin McCarthy got to yes on their debt-ceiling compromise
- Global stock markets breathe a sigh of relief over Biden-McCarthy pact to avert U.S. debt default
- ‘He’s content living paycheck to paycheck’: My husband won’t work or get a driver’s license. Now things have gotten even worse.
- Don’t get stung by buy-now- pay-later services: ‘It is kind of a recipe for disaster if not managed carefully’
to be replaced
Elevation Oncology Inc.
ELEVUS
$
-0.04
-0.80%
After Hours
$
4.98
After Hours Volume:
639.74K
| Close | Chg | Chg % |
|---|---|---|
| $5.02 | 2.01 | 66.78% |
Volume: 66.83M
65 Day Avg: 1.88M
4.37
Day Range
5.89
0.72
52 Week Range
5.89
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
ELEV Overview
Key Data
- Open $5.70
- Day Range 4.37 - 5.89
- 52 Week Range 0.72 - 5.89
- Market Cap $122.18M
- Shares Outstanding 24.34M
- Public Float 16.11M
- Beta 0.75
- Rev. per Employee N/A
- P/E Ratio N/A
- EPS -$4.06
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 369.12K 05/15/23
- % of Float Shorted 2.29%
- Average Volume 1.88M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 3
Full Ratings
Recent News
Elevation Oncology downgraded to underweight from neutral at J.P. Morgan
Elevation Oncology downgraded to neutral from overweight at J.P. Morgan
Elevation Oncology stock price target cut to $21 from $27 at Wedbush
Elevation Oncology started at outperform with $27 stock price target at Wedbush
12 Health Care Stocks Moving In Monday's Intraday Session
on Benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
on Benzinga.com
Elevation Oncology Blasts Higher on New Cancer Treatment
on TipRanks.com
12 Health Care Stocks Moving In Friday's Intraday Session
on Benzinga.com
PARA Stock Alert: The $125 Million Reason Paramount Shares Are Up Today
on InvestorPlace.com
PLTR Stock Alert: Palantir Announces AI Event
on InvestorPlace.com
Nasdaq Rises 1%; US Goods Trade Gap Widens In April
on Benzinga.com
Why Is Elevation Oncology (ELEV) Stock Up 57% Today?
on InvestorPlace.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
on Benzinga.com
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
on InvestorPlace.com
12 Health Care Stocks Moving In Friday's Intraday Session
on Benzinga.com
Elevation Oncology (ELEV) Gets a Hold from SVB Securities
on TipRanks.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
on Benzinga.com
Elevation Oncology Inc.
Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in New York, NY.